Outcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 83
- Locations
- 1
- Primary Endpoint
- Short Form-36 Health Status Questionnaire
Study Overview
Brief Summary
Outcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation are not known in china.A cross-section survey will be performed to assess the long-term outcome of these patients.
Detailed Description
Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2011 to March 1,2017 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expected mortality) and related treatment conditions(duration of ICU stay, duration of ECMO,duration of mechanical ventilation,ventilation conditions,prone ventilation,ECMO complications )will be used to assess the severity and curative effect of these patients.Short Form-36 Health Status Questionnaire,EuroQol-5 Dimensions and St. George's Respiratory Questionnaire(SGRQ) will deliver in these survivors ,which are used to assess the physical and mental health ,as well as the social adaptation. Finally a comprehensive assessment will be obtained to describe the outcomes and long-term quality-of-life of patients treated With ECMO.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients treated with ECMO
Exclusion Criteria
- •non-survivors of patients treated with ECMO,declined or lost to follow up
Outcomes
Primary Outcomes
Short Form-36 Health Status Questionnaire
Time Frame: June,2017-May,2018
SF-36 is now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
Secondary Outcomes
- EuroQol-5 Dimensions(June,2017-May,2018)
- the St. George's Respiratory Questionnaire(SGRQ)(June,2017-May,2018)
Investigators
Ling Liu
Dr.
Southeast University, China
